Tiaa, Fsb Moderna, Inc. Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Moderna, Inc. stock. As of the latest transaction made, Tiaa, Fsb holds 5,015 shares of MRNA stock, worth $329,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,015

Previous 4,898 2.39%

Holding current value

$329,736

Previous $752,000 19.02%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $13,864 - $18,782	117 Added 2.39%	5,015 $609,000
Q1 2023 Apr 19, 2023	SELL	$135.66 - $197.02 $57,384 - $83,339	-423 Reduced 7.95%	4,898 $752,000
Q4 2022 Jan 12, 2023	BUY	$118.38 - $210.04 $225,158 - $399,496	1,902 Added 55.63%	5,321 $956,000
Q3 2022 Oct 11, 2022	SELL	$118.07 - $194.18 $58,208 - $95,730	-493 Reduced 12.6%	3,419 $404,000
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $458,212 - $690,820	3,912 New	3,912 $559,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account